Patents by Inventor Anne Milner

Anne Milner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Hybrid interfering RNA
    Patent number: 8067572
    Abstract: The invention relates to a hybrid interfering RNA molecule comprising a duplex RNA and a single stranded DNA molecule and its use in the ablation of mRNA and in polymerase chain reactions.
    Type: Grant
    Filed: May 24, 2006
    Date of Patent: November 29, 2011
    Assignee: The University of York
    Inventors: Josephine Anne Milner, Michael Gait, Ming Jiang, Andrei Arzumanov
  • COMBINATION THERAPY
    Publication number: 20110060028
    Abstract: This disclosure relates to a SIRT1 polypeptide and a treatment regime that inhibits the activity of SIRT1 and including a method of diagnosis.
    Type: Application
    Filed: August 15, 2008
    Publication date: March 10, 2011
    Applicant: UNIVERSITY OF YORK
    Inventor: Josephine Anne Milner
  • Hybrid Interfering Rna
    Publication number: 20090012022
    Abstract: The invention relates to a hybrid interfering RNA molecule comprising a duplex RNA and a single stranded DNA molecule and its use in the ablation of mRNA and in polymerase chain reactions.
    Type: Application
    Filed: May 24, 2006
    Publication date: January 8, 2009
    Inventors: Josephine Anne Milner, Michael Gait, Ming Jiang, Andrei Arzumanov
  • Induction of apoptosis by inhibition of sirtuin sirta expression
    Publication number: 20070197459
    Abstract: The invention relates to the induction of apoptosis by inhibition of the sirtuin SIRT1 expression, in particular the induction of apoptosis in tumour cells. Materials and methods for inhibiting SIRT1 expression are provided, including RNA interference methods. In particular, the invention provides a method of treating a proliferative disease comprising administering to an individual in need thereof an effective amount of a SIRT1 inhibitor.
    Type: Application
    Filed: February 11, 2005
    Publication date: August 23, 2007
    Inventor: Anne Milner